Pfizer's Maddaluna on Integrating Wyeth's Manufacturing Organization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pfizer’s Maddaluna on Integrating Wyeth’s Manufacturing Organization



Anthony J. Maddaluna
Senior Vice President, PGM Strategy and Supply Network Transformation
Pfizer, Inc.

Add this Podcast feed to your media player



What is the future of Pfizer’s global manufacturing network following the Wyeth acquisition? In this interview, Tony Maddaluna, senior vice-president of Strategy and Supply Network Transformation at Pfizer Global Manufacturing (PGM), outlines the company’s plans for manufacturing integration.

More Podcasts>>

Related Topic

Big Pharma Tightens Its Global Manufacturing Belt (August 2009)


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search

Click here